http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11130682-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6deefe8592a7bd0a281f5753c63f2de1 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 |
filingDate | 1997-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7932442b24e015d078b09015c7f8e3c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cca9d469d84b584d735f432190f9395e |
publicationDate | 1999-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H11130682-A |
titleOfInvention | Thermostabilization of blood coagulation factor XIII |
abstract | PROBLEM TO BE SOLVED: To provide a solution obtained by a conventional method using glycine and sucrose in a virus inactivation treatment by heating a solution containing blood coagulation factor XIII (hereinafter referred to as factor XIII) using glycine and sucrose. In the present invention, the presence of serine and a saccharide, particularly sucrose, in a constant concentration in a factor XIII-containing solution reduces the occurrence of turbidity without lowering the residual activity of factor XIII compared to the conventional method. Succeeded. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001327592-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019182123-A1 |
priorityDate | 1997-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.